With restored circulation, the TAH allowed Harbison to regain enough strength within 10 days to also undergo a heart ...

The device is in the early stages of approval by the US Food and Drug Administration and only a few have been implanted in ...

For years, it was shrouded in secrecy. It was heart surgery’s Manhattan Project, whispered to be set to change the world. And ...

A Graham man became the second person in the world to receive the device, which provides a bridge to transplant A young Graham, N.C., father became the second person in the world to receive a BiVACOR ...

The man received the device earlier this month and has since gotten a "real heart transplant." The goal of the artificial ...

30 patients had successfully undergone heart transplant after being supported by the Aeson® artificial heart, confirming the ability of the device to provide physiological support tailored to each ...

The BiVACOR Total Artificial Heart was implanted in a patient at The Christ Hospital Health Network recently in Cincinnati, ...

These 30 patients benefited from Aeson® support for an average of 156 days before transplant (the maximum duration recorded being 308 days). As a reminder, the Aeson® artificial heart is CE ...

A team of UC students are in Japan for the global Heart Hackathon, a competition to build a fully operational artificial ...

A new contender has now arrived in the BiVACOR TAH (total artificial heart ... being tested as a bridge-to-transplant solution, for patients with a failing heart who do not qualify for a ...

The Duke University Health System was responsible for the second-ever utilization of a technology that acts as a complete artificial heart to extend the lives of patients waiting for a transplant.